According to Ardelyx's latest financial reports and stock price the company's current Operating Margin is -104.48%. At the end of 2021 the company had an Operating Margin of -1,521.83%.
Year | Operating Margin | Change |
---|---|---|
2021 | -1,521.83% | 29.15% |
2020 | -1,178.34% | -30.01% |
2019 | -1,683.60% | -49.99% |
2018 | -3,366.32% | 2071.32% |
2017 | -155.04% | |
2015 | -122.32% | 2373.26% |
2014 | -4.95% | -50.06% |
2013 | -9.90% | -93.91% |
2012 | -162.75% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 15.60% | -114.93% | ๐บ๐ธ USA |
Amgen AMGN | 34.59% | -133.11% | ๐บ๐ธ USA |
Sanofi SNY | 18.21% | -117.43% | ๐ซ๐ท France |
AstraZeneca AZN | 5.63% | -105.39% | ๐ฌ๐ง UK |
OPKO Health
OPK | -36.36% | -65.20% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.